Blepharophimosis-Epicanthus Inversus-Ptosis Syndrome (BPES)

Blepharophimosis-Epicanthus Inversus-Ptosis Syndrome (BPES) is a rare condition that affects the eyelids from birth. The eye openings are narrow from side to side (blepharophimosis). There is a skin fold that runs from the lower eyelid upward near the inner corner of the eye (epicanthus inversus). The upper eyelids droop (ptosis) and can cover part of the pupils. The condition usually affects both eyes. It is caused most often by changes in a gene called FOXL2, which helps eyelid tissues grow and work normally. BPES can occur alone (Type I or Type II) or with reduced ovarian function in people who can become pregnant (Type I), which may lead to early menopause and trouble having children. BPES does not affect intelligence. People with BPES may need surgery to open the eyelids wider, improve vision, and support normal face growth. Early eye checks are important to prevent lazy eye.

BPES is a birth condition that mainly changes the eyelids and how they open. Babies are born with four hallmark features:

1. Blepharophimosis—the eye opening is shorter from side to side.

2. Ptosis—the upper eyelids droop.

3. Epicanthus inversus—a skin fold rises from the lower lid and runs up toward the inner corner of the eye.

4. Telecanthus—the inner eye corners sit farther apart than usual, even though the pupils are normally spaced.
   These features are present in both eyes and from birth. The condition is usually caused by a change (mutation) in a single gene called FOXL2 on chromosome 3, which is important for eyelid and ovarian development. Most people inherit it in an autosomal dominant way (one changed copy of the gene is enough), but new (de novo) mutations are also common. NCBI+1

Other names

• Blepharophimosis syndrome

• BPES

• Blepharophimosis–ptosis–epicanthus inversus
  These are all accepted synonyms and refer to the same disorder. NCBI

Types

There are two classic types:

• Type I BPES: has the four eyelid features plus a risk of primary ovarian insufficiency (POI) in females (menstrual periods may stop early, and fertility can be reduced). NCBI

• Type II BPES: has only the eyelid features, without ovarian problems. NCBI

Doctors sometimes use “BPES-plus” when the chromosome deletion is larger than the FOXL2 gene and nearby genes are also missing, leading to extra problems such as developmental delay or genital differences—this is less common. Orpha.net

---

Causes

BPES is one disease with one main gene, FOXL2. Below are different ways that gene can be altered or regulated to cause the same syndrome.

1. FOXL2 loss-of-function (haploinsufficiency): one copy does not make enough working protein, so eyelid and ovarian development are affected. NCBI

2. Missense variants: a single “letter” change alters one amino acid in FOXL2 and disrupts its function. NCBI+1

3. Nonsense variants: a change creates a stop signal; the protein is cut short and cannot work. NCBI

4. Frameshift variants: small insertions or deletions shift the reading frame, producing a faulty protein. NCBI

5. Splice-site variants: changes at exon–intron boundaries prevent proper RNA splicing of FOXL2. NCBI

6. Polyalanine expansions: a repeated alanine stretch in FOXL2 is abnormally long; this well-known mechanism can cause BPES. NCBI

7. Whole-gene deletions: the entire FOXL2 gene is missing on one chromosome. NCBI

8. Partial FOXL2 deletions/duplications (CNVs): only part of the gene is missing or duplicated; either can disturb protein function. NCBI

9. 3q23 regulatory region deletions: the gene is intact, but nearby control DNA is missing, so FOXL2 is not switched on correctly. Orpha.net

10. Chromosomal translocations involving 3q23: a chromosome break disrupts FOXL2 or its control elements. NCBI

11. Promoter variants: changes in the “on/off switch” region reduce FOXL2 expression. MDPI

12. Dominant-negative FOXL2 effects: some abnormal proteins can interfere with the normal copy’s function. MDPI

13. De novo variants: a new mutation appears for the first time in the child; parents test negative. NCBI

14. Mosaicism: only some cells carry the variant, which can alter severity and recurrence risk. NCBI

15. Biallelic polyalanine expansion (very rare): when both copies carry a small expansion, typical BPES can occur (reported in one family). NCBI

16. FOXL2 interaction network disruption: changes that impair FOXL2’s partners or DNA binding reduce its activity. MDPI

17. Epigenetic dysregulation of FOXL2: abnormal gene regulation (e.g., methylation) may reduce expression (inferred from FOXL2 biology). MDPI

18. Large 3q22.3–q23 microdeletions (“BPES-plus”): FOXL2 plus neighboring genes are deleted, adding extra features. NCBI

19. Paternal transmission bias: families may show stronger transmission through fathers (observational genetic finding). NCBI

20. General FOXL2 pathway failure in ovary: in Type I, FOXL2 dysfunction can impair ovarian cells, causing POI. BioMed Central+1

---

Symptoms and signs

1. Narrow eye openings from side to side (blepharophimosis). This is present at birth and makes the eyes look small. NCBI

2. Droopy upper eyelids (ptosis). Children often raise their brows or tilt the chin up to see better. NCBI

3. Skin fold from lower lid upward (epicanthus inversus). It sits at the inner eye corner and can hide part of the inner eye. NCBI

4. Inner eye corners far apart (telecanthus) even though the pupils are normally spaced. NCBI

5. Amblyopia (“lazy eye”) risk if the droopy lids or refractive error block clear vision during childhood. NCBI

6. Refractive errors (needing glasses), including astigmatism, can happen and add to the amblyopia risk. NCBI

7. Strabismus (eye misalignment) may occur in some patients. NCBI

8. Lacrimal drainage issues (watery eyes/tearing). Congenital nasolacrimal duct obstruction has been reported; it is not universal but worth checking. PubMed+1

9. Dry eye or irritation due to abnormal lid position and blink. NCBI

10. Frontal headaches or neck strain from a chronic “chin-up” head posture used to see under droopy lids. ScienceDirect

11. Eyelid skin differences (thin skin, poorly formed eyelid creases). NCBI

12. Broad nasal bridge or low-set ears may be noted by clinicians in some individuals. NCBI

13. Type I only—menstrual and fertility problems in females: irregular or absent periods, hot flashes, and difficulty conceiving due to POI. NCBI+1

14. Psychosocial impact (appearance concerns, teasing, self-esteem issues), often improved after surgery and vision care. NCBI

15. Rare “BPES-plus” features when larger 3q deletions are present (e.g., learning difficulties). These suggest testing for big chromosomal changes. NCBI

---

Diagnostic tests

A. Physical examination (bedside checks)

1. Facial/eyelid inspection: confirm the four hallmark features and overall facial symmetry. Measurements guide planning. NCBI

2. Horizontal fissure length: adults with BPES typically measure ~20–22 mm vs. 25–30 mm in unaffected adults. NCBI

3. Margin-reflex distance 1 (MRD1): measures how far the upper lid sits above the pupil light reflex; low MRD1 confirms ptosis severity. EyeWiki

4. Levator function test: measures upper-lid muscle up-and-down movement to plan ptosis surgery. NCBI

5. Inner canthal distance and interpupillary distance: documents telecanthus with normal pupil spacing. NCBI

B. Manual/functional vision tests

6. Age-appropriate visual acuity (e.g., Teller cards, Lea symbols, Snellen letters): checks for amblyopia early. NCBI

7. Cycloplegic refraction: finds hidden farsightedness/astigmatism that needs glasses to prevent amblyopia. NCBI

8. Cover-uncover and alternate cover tests: screens for strabismus that can worsen visual development. NCBI

9. External photos/serial measurements: track growth, posture, and surgical results over time. EyeWiki

10. Lacrimal probing/fluorescein dye disappearance (in infants with tearing): screens for nasolacrimal blockage. AAP Publications

C. Laboratory / pathological (genetic and hormonal testing)

11. FOXL2 sequencing (Sanger/NGS): looks for single-letter changes, small insertions/deletions. Confirms the diagnosis when positive. ScienceDirect+1

12. FOXL2 deletion/duplication testing (MLPA or CNV by NGS): finds missing or extra gene segments not seen on routine sequencing. Orpha.net

13. Chromosomal microarray: detects larger 3q22.3–q23 deletions that cause BPES-plus features. NCBI

14. Karyotype/FISH for 3q23: looks for translocations or targeted deletions involving the FOXL2 region. Orpha.net

15. POI hormone panel in at-risk females (Type I): FSH/LH high, estradiol low; AMH and antral follicle count help estimate ovarian reserve. BioMed Central

D. Electrodiagnostic tests (used only when needed)

16. Visual evoked potentials (VEP): used if visual pathway function is unclear (e.g., dense ptosis or suspected amblyopia impact). (Clinical practice consideration; not routine.) NCBI

17. Electroretinography (ERG): seldom required; may help if other retinal causes of reduced vision are suspected. (Differential diagnosis context.) NCBI

E. Imaging tests

18. Slit-lamp biomicroscopy and eyelid/meibomian exam: checks ocular surface health in dry eye or exposure. NCBI

19. Dacryocystography or nasal endoscopy (selected cases with persistent tearing): defines nasolacrimal obstruction before surgery. Lippincott Journals

20. Pelvic ultrasound (Type I risk): evaluates ovarian size and follicle count during fertility assessment; MRI if needed by gynecology. Frontiers

Non-pharmacological treatments (therapies and other supports)

1) Early pediatric ophthalmology monitoring
Description: Regular eye exams start in the first months of life. The doctor checks eyelid height, pupil coverage, eye alignment, refraction (need for glasses), and signs of lazy eye. Visits are more frequent in the first years when the brain learns to see. The team also screens for tear drainage issues and corneal dryness because narrow palpebral fissures can upset tear spread. Parents learn what warning signs to watch for, like head tilting, brow lifting, or one eye turning in. Early findings guide timing for glasses, patching, and surgery.
Purpose: Catch vision problems early and prevent amblyopia (lazy eye).
Mechanism: Repeated measurement and observation identify risks to visual development so care can be started when the brain is most able to adapt. Evidence note: Standard pediatric ophthalmology practice for congenital ptosis/eyelid disorders.

2) Amblyopia (lazy eye) therapy
Description: If one eye sees weaker, the stronger eye may be briefly covered with a patch or blurred with a drop (as directed by a doctor). Sessions are short at first, then adjusted based on response. Parents receive coaching on comfort and safety. The team tracks vision with age-appropriate charts. Therapy continues until the two eyes are closer in strength.
Purpose: Improve vision in the weaker eye and support binocular vision.
Mechanism: Short, controlled reduction of the better eye’s input forces the brain to use the weaker eye, strengthening the visual pathway. Evidence note: Amblyopia treatment is a core guideline in pediatric eye care.

3) Refractive correction (glasses/contacts)
Description: Children with BPES can have farsightedness, astigmatism, or other refractive errors. Early glasses correct blur and reduce eye strain. As the face grows and surgeries occur, prescriptions are updated. Some teens and adults may choose contacts under specialist guidance if eyelid anatomy allows safe wear.
Purpose: Give the retina a clear image to support normal visual development.
Mechanism: Lenses focus light correctly on the retina. Clear input lowers the risk of amblyopia and headaches. Evidence note: Refractive correction is standard of care for pediatric visual development.

4) Lubrication and eyelid hygiene
Description: Artificial tears, nighttime gels, and simple eyelid cleaning help reduce dryness and irritation. Warm compresses may be used to improve oil gland flow in the lids. Parents learn gentle techniques and frequency based on symptoms and doctor advice.
Purpose: Protect the cornea and improve comfort.
Mechanism: Lubricants improve the tear film. Hygiene reduces debris and improves tear quality, lowering friction on the cornea. Evidence note: Accepted first-line care for eyelid-related dry eye.

5) Taping/positioning guidance in infancy
Description: In selected infants with significant pupil coverage before surgery, short-term careful lid taping techniques may be taught by clinicians to keep the visual axis clear during key waking periods, with strict skin-safety and timing rules. This is not a long-term solution and is done only under medical guidance.
Purpose: Reduce time the pupil is blocked before surgery can be safely done.
Mechanism: Mechanical lifting of the lid lets light reach the retina, lowering amblyopia risk. Evidence note: Used judiciously in congenital ptosis management when clinically indicated.

6) Developmental and educational support
Description: Some children may develop compensatory head postures or fatigue from working to raise lids. Simple classroom adaptations help, like sitting closer to the board, better lighting, frequent visual breaks, and large-print materials when needed. Teachers receive notes from the eye team.
Purpose: Support learning and reduce visual strain.
Mechanism: Environmental adjustments lower the workload on the eyelids and visual system, helping attention and comfort. Evidence note: Standard accommodations for pediatric vision disorders.

7) UV and glare protection
Description: Sunglasses and hats with brims reduce glare, which can be worse when tear film is unstable or the lids do not spread tears evenly. Children are encouraged to build the habit early.
Purpose: Improve comfort outdoors and protect the ocular surface.
Mechanism: Lower UV and bright light exposure reduces squinting and dryness triggers. Evidence note: General ocular surface protection guidance.

8) Nutritional counseling for eye surface health
Description: A varied diet with omega-3-rich foods (fish, flax), leafy greens, and adequate hydration supports the tear film and ocular surface. For picky eaters, a pediatric clinician or dietitian helps plan practical choices the child will accept.
Purpose: Support tear quality and overall eye health.
Mechanism: Omega-3s and antioxidants can support meibomian gland function and the ocular surface. Evidence note: Dietary support is commonly recommended for dry eye tendencies.

9) Family genetic counseling
Description: Because BPES is often autosomal dominant, a genetic counselor explains inheritance, testing options, and family planning including the Type I link with primary ovarian insufficiency. Counseling helps relatives decide on evaluation and plan for life events.
Purpose: Inform families and support health planning.
Mechanism: Education plus testing clarifies risk and guides screening or early care. Evidence note: Standard practice for FOXL2-related disorders.

10) Psychosocial support and counseling
Description: Differences in eyelid appearance can affect self-image, especially in school years. Age-appropriate counseling, peer support, and preparation for surgery reduce anxiety. Parents also benefit from stress-management tools and support groups.
Purpose: Improve coping, confidence, and quality of life.
Mechanism: Counseling builds skills to manage social challenges and medical procedures. Evidence note: Routine supportive care in pediatric craniofacial differences.

11) Occupational/vision therapy for functional goals
Description: When head posture or fatigue affects daily activities, therapists teach energy-saving techniques, optimal reading angles, and eye-hand coordination games.
Purpose: Make daily tasks easier and safer.
Mechanism: Task-specific practice builds efficient habits and reduces strain. Evidence note: Used across pediatric visual dysfunction care.

12) Sleep and screen-time hygiene
Description: Adequate sleep, timed breaks during near work, and “20-20-20” rest rules reduce dryness and eye fatigue.
Purpose: Lower symptoms and support attention.
Mechanism: Regular breaks and sleep help blinking and tear film stability. Evidence note: Common behavioral advice for eye strain.

13) Warm compress and lid massage routines
Description: Gentle, brief warm compresses followed by light lid massage may improve meibomian oil flow, enhancing tear stability when advised by a clinician.
Purpose: Ease dryness and irritation.
Mechanism: Heat liquefies meibum, massage helps express oils to the tear film. Evidence note: Standard dry eye adjunct.

14) Protective eyewear in sports
Description: Proper sports goggles protect eyes during play, especially after surgery or when dry eye is present.
Purpose: Prevent injuries.
Mechanism: Impact-resistant shields reduce trauma risk. Evidence note: Sports eye safety guidelines.

15) Post-surgical care education
Description: Families learn how to clean incisions, use cold compresses, respect activity limits, and watch for warning signs like swelling, discharge, or vision change.
Purpose: Promote healing and avoid complications.
Mechanism: Good wound care lowers infection and scarring risk. Evidence note: Standard postoperative instructions.

16) Sun and wind avoidance during recovery
Description: Temporary limits on windy or dusty environments help the surface heal after eyelid surgery.
Purpose: Reduce irritation.
Mechanism: Less exposure lowers tear evaporation and mechanical stress. Evidence note: Typical postoperative advice.

17) Eye-safe classroom and home lighting
Description: Even, indirect lighting helps reduce glare and squinting. Task lights are set behind the reader’s shoulder.
Purpose: Improve visual comfort.
Mechanism: Balanced light reduces reflex squint and fatigue. Evidence note: General low-vision ergonomics.

18) Caregiver training for medicated drop/gel use
Description: If drops are prescribed (e.g., for lubrication), caregivers learn correct technique to avoid touching the eye or lashes and to space different products.
Purpose: Improve effectiveness and safety.
Mechanism: Proper instillation increases ocular surface coverage and reduces contamination. Evidence note: Core patient-education practice.

19) School care plan
Description: A written plan covers seating, visual breaks, access to notes, and nurse contact after surgery.
Purpose: Keep learning smooth around medical care.
Mechanism: Predictable supports reduce missed content and stress. Evidence note: Standard for chronic pediatric conditions.

20) Transition planning to adult care
Description: As teens grow, they learn their diagnosis, surgery history, and signs that need care. They receive a summary to take to adult providers, including any reproductive health notes for Type I BPES.
Purpose: Keep care continuous and informed.
Mechanism: Hand-off documents reduce gaps and delays. Evidence note: Best practice in lifelong conditions.

---

Drug treatments

There is no single “BPES drug” that fixes the eyelid shape. Medicines help with associated issues like dry eye, infections, inflammation, allergies, pain control around surgery, and amblyopia support regimens. Below are FDA-approved drug types commonly used in pediatric ophthalmology or peri-operative eyelid care. For each, I include a ~150-word description, class, typical pediatric-style dosing guidance (doctors individualize this), timing, purpose, mechanism, and common side effects. Always follow your clinician’s exact prescription.
(Source style: FDA prescribing information/labels hosted at accessdata.fda.gov for each named example agent or class.)

1) Preservative-free artificial tears (e.g., carboxymethylcellulose)
Description: Single-use, preservative-free tear drops soothe dryness and protect the cornea when lids do not spread tears well. They are safe for frequent daytime use and gentle on sensitive eyes.
Class: Ocular lubricant.
Dosage/Time: 1–2 drops per eye as needed; frequency individualized.
Purpose: Moisturize and protect the eye surface.
Mechanism: Polymers hold water on the cornea, improving tear film stability.
Side effects: Brief blur, mild irritation. Rare allergy.
Evidence reference: FDA-listed ocular lubricants; see artificial tear product labels on accessdata.fda.gov.

2) Nighttime ophthalmic gels/ointments (e.g., white petrolatum/mineral oil)
Description: Thick gels or ointments coat the eye overnight to reduce friction and morning irritation.
Class: Ocular lubricant/protectant.
Dosage/Time: Small ribbon inside lower lid at bedtime.
Purpose: Overnight protection.
Mechanism: Occlusive layer slows evaporation.
Side effects: Temporary blur, sticky lashes.
FDA label reference: Petrolatum-based ophthalmic ointments.

3) Topical antihistamine/mast-cell stabilizer (e.g., olopatadine)
Description: If itching or allergies worsen surface symptoms, dual-action drops reduce allergic inflammation and rubbing.
Class: Antihistamine/mast-cell stabilizer.
Dosage/Time: Usually 1 drop once or twice daily per label.
Purpose: Control allergy signs.
Mechanism: Blocks H1 receptors and stabilizes mast cells to reduce histamine release.
Side effects: Mild sting, dry eye, headache.
FDA label reference: Olopatadine ophthalmic solutions.

4) Topical corticosteroids (short, supervised use; e.g., loteprednol)
Description: For significant inflammation after surgery or surface flare, doctor may use a mild steroid drop for a short time.
Class: Ophthalmic corticosteroid.
Dosage/Time: Short course per surgeon’s plan; taper as directed.
Purpose: Calm inflammation and swelling.
Mechanism: Suppresses inflammatory cytokines.
Side effects: IOP rise, delayed healing, infection risk; requires follow-up.
FDA label reference: Loteprednol ophthalmic suspension/gel.

5) Topical calcineurin inhibitor (e.g., cyclosporine ophthalmic emulsion)
Description: In older children or adults with chronic surface inflammation not controlled by tears, cyclosporine may be used.
Class: Immunomodulator.
Dosage/Time: 1 drop twice daily as labeled, age-appropriate use per clinician.
Purpose: Improve tear production and reduce inflammation.
Mechanism: Inhibits T-cell activation in lacrimal tissue.
Side effects: Temporary burning, redness.
FDA label reference: Cyclosporine ophthalmic (e.g., Restasis) labeling.

6) Lifitegrast ophthalmic solution
Description: Another option for dry eye in suitable ages, guided by specialist.
Class: LFA-1 antagonist.
Dosage/Time: 1 drop twice daily.
Purpose: Reduce eye surface inflammation.
Mechanism: Blocks LFA-1/ICAM-1 interaction to limit T-cell-mediated inflammation.
Side effects: Dysgeusia (taste change), irritation.
FDA label reference: Lifitegrast label.

7) Broad-spectrum topical antibiotic (e.g., moxifloxacin) for post-op prophylaxis if indicated
Description: Short course after surgery to lower infection risk as directed by surgeon.
Class: Fluoroquinolone antibiotic (ophthalmic).
Dosage/Time: Per label for postoperative prophylaxis.
Purpose: Prevent/treat bacterial infection.
Mechanism: Inhibits bacterial DNA gyrase.
Side effects: Stinging, rare hypersensitivity.
FDA label reference: Moxifloxacin ophthalmic solution.

8) Oral antibiotic for preseptal cellulitis if needed (e.g., amoxicillin-clavulanate)
Description: If eyelid infection occurs, oral antibiotics may be used based on age and local patterns.
Class: Beta-lactam/beta-lactamase inhibitor.
Dosage/Time: Weight-based pediatric dosing.
Purpose: Treat bacterial soft tissue infection.
Mechanism: Inhibits bacterial cell wall synthesis.
Side effects: GI upset, rash.
FDA label reference: Amoxicillin-clavulanate.

9) Topical NSAID (e.g., ketorolac ophthalmic) for short-term pain/inflammation
Description: May be used briefly after certain procedures to reduce discomfort under surgeon guidance.
Class: Nonsteroidal anti-inflammatory (ophthalmic).
Dosage/Time: Per label for short course.
Purpose: Reduce pain/inflammation.
Mechanism: COX inhibition lowers prostaglandins.
Side effects: Sting, delayed healing risk; avoid overuse.
FDA label reference: Ketorolac tromethamine ophthalmic.

10) Systemic analgesics (e.g., acetaminophen, ibuprofen age-appropriate)
Description: Doctor-advised pain relief after surgery.
Class: Analgesic/antipyretic; NSAID.
Dosage/Time: Weight-based; limited duration.
Purpose: Comfort and quicker recovery.
Mechanism: Central COX inhibition (acetaminophen); peripheral COX inhibition (ibuprofen).
Side effects: GI upset (NSAIDs), liver risk if overdosed (acetaminophen).
FDA label reference: OTC drug facts/labels.

11) Topical antibiotic-steroid combination (short term) when clinically justified
Description: For postoperative inflammation with infection risk, a combination ointment may be used briefly.
Class: Antibiotic + corticosteroid ophthalmic.
Dosage/Time: Short, tapered course.
Purpose: Control inflammation and cover common bacteria.
Mechanism: Anti-inflammatory + antimicrobial actions.
Side effects: IOP rise, delayed healing, allergy.
FDA label reference: Various combo products.

12) Antiallergy oral antihistamines (age-appropriate)
Description: Reduce systemic allergy that worsens eye rubbing.
Class: H1 antihistamine.
Dosage/Time: As labeled by age/weight.
Purpose: Cut itch and rubbing that can irritate lids.
Mechanism: H1 receptor blockade.
Side effects: Drowsiness (older agents), dry mouth.
FDA label reference: OTC/ Rx antihistamines.

13) Nasal steroids for allergic rhinitis (indirect eye benefit)
Description: Treating nose allergy can reduce reflex eye irritation.
Class: Intranasal corticosteroid.
Dosage/Time: Daily per label.
Purpose: Lower overall atopy burden.
Mechanism: Local anti-inflammatory effect.
Side effects: Nose irritation, epistaxis.
FDA label reference: Fluticasone, mometasone nasal labels.

14) Lubricating gel inserts (hydroxypropyl cellulose; for appropriate ages)
Description: Slow-release inserts may help selected older patients with severe dryness.
Class: Ocular lubricant insert.
Dosage/Time: Once daily, per label.
Purpose: All-day moisture.
Mechanism: Polymer gel slowly dissolves to stabilize tears.
Side effects: Foreign body sensation.
FDA label reference: Hydroxypropyl cellulose insert.

15) Antibiotic ointment for lash hygiene when blepharitis coexists (e.g., erythromycin)
Description: Short course at night with lid hygiene for crusting.
Class: Macrolide antibiotic (ophthalmic).
Dosage/Time: Thin ribbon nightly x short course.
Purpose: Reduce bacterial load on lid margin.
Mechanism: Protein synthesis inhibition.
Side effects: Irritation, allergy.
FDA label reference: Erythromycin ophthalmic ointment.

16) Short course decongestant-free lubricants vs vasoconstrictors
Description: Avoid chronic “redness relief” vasoconstrictor drops; prefer lubricants.
Class: Lubricants preferred; vasoconstrictors are not for chronic use.
Dosage/Time: As needed lubricants.
Purpose: Safe comfort without rebound redness.
Mechanism: Moisturization vs transient vessel constriction.
Side effects: Vasoconstrictors can cause rebound hyperemia if misused.
FDA label reference: OTC eye drop labels.

17) Peri-operative antiemetics (e.g., ondansetron) if anesthesia requires
Description: Used around surgery to reduce nausea/vomiting.
Class: 5-HT3 antagonist.
Dosage/Time: Single dose per anesthesia plan.
Purpose: Comfort and safety post-op.
Mechanism: Blocks serotonin receptors in gut/brain.
Side effects: Headache, constipation.
FDA label reference: Ondansetron labeling.

18) Peri-operative antibiotics per surgical protocol
Description: Surgeon may order a single pre-op dose based on local standards.
Class: Systemic antibiotic.
Dosage/Time: One-time pre-op dose if indicated.
Purpose: Lower infection risk.
Mechanism: Bactericidal activity at incision time.
Side effects: Allergy, GI upset.
FDA label reference: Class-specific labels.

19) Short course oral steroids only for specific indications
Description: Rarely used; the surgeon may prescribe a brief taper for significant inflammation.
Class: Systemic corticosteroid.
Dosage/Time: Brief taper.
Purpose: Reduce severe swelling.
Mechanism: Broad anti-inflammatory effects.
Side effects: Mood change, glucose effects, infection risk.
FDA label reference: Prednisone label.

20) Antibiotic prophylaxis for tear duct procedures if performed
Description: If ancillary tear-duct work is done, targeted antibiotics may be used.
Class: Topical or systemic antibiotic per procedure.
Dosage/Time: Short course.
Purpose: Prevent infection.
Mechanism: Lowers bacterial load at procedure site.
Side effects: Class-specific.
FDA label reference: Per chosen agent’s FDA label.

Dietary molecular supplements

Supplements do not change eyelid shape. They may support the ocular surface, healing, and overall eye comfort. Quality varies; use reputable products and physician guidance, especially in children.

1) Omega-3 fatty acids (EPA/DHA)
Description (150 words): Omega-3s from fish oil or algae can improve tear quality in some people with dry eye tendencies. They may reduce inflammation in the eyelid oil glands, helping tears spread better over the eye. For children, dosing should be tailored with a pediatric clinician who checks for fish or shellfish allergies and reviews diet. In teens and adults, common daily EPA/DHA totals range from about 500–1000 mg, but doctors individualize plans. Take with meals to reduce fishy aftertaste. Choose purified products tested for heavy metals.
Dosage: Typical combined EPA+DHA 500–1000 mg/day for older patients; pediatric dosing individualized.
Function/Mechanism: Anti-inflammatory lipid mediators; support meibomian gland function and tear film stability.

2) Vitamin A (within safe limits)
Description: Vitamin A supports the eye surface and goblet cells that make mucin for tears. Deficiency is uncommon in high-income settings but can occur with limited diets. Excess can be toxic, so a clinician should guide dosing, especially for children and pregnant individuals.
Dosage: Usually from diet or low-dose multivitamin; avoid high doses.
Function/Mechanism: Supports epithelial health and mucin production.

3) Vitamin D
Description: Low vitamin D has been linked to surface discomfort in some studies. Supplement only if low, based on a clinician’s advice.
Dosage: Per blood level and age.
Function/Mechanism: Immunomodulatory effects that may support ocular surface comfort.

4) Vitamin C
Description: Supports collagen synthesis and wound healing after procedures.
Dosage: Diet first; supplement at standard age-appropriate doses if advised.
Function/Mechanism: Cofactor in collagen cross-linking and antioxidant defense.

5) Vitamin E
Description: Antioxidant support when diet is low; avoid high doses before surgery unless surgeon approves.
Dosage: Dietary intake or modest supplement.
Function/Mechanism: Membrane antioxidant; may protect tear film lipids.

6) Zinc
Description: Helps wound repair and immune function; excess can upset copper balance.
Dosage: Age-appropriate RDA; supplement only if needed.
Function/Mechanism: Enzyme cofactor in repair and immunity.

7) L-carnitine
Description: Sometimes used for cellular energy support; limited direct eye data in BPES.
Dosage: As advised by clinician.
Function/Mechanism: Fatty acid transport into mitochondria; potential anti-oxidative effects.

8) N-acetylcysteine (NAC)
Description: Mucolytic and antioxidant; occasionally used off-label for meibomian and tear issues in older patients under supervision.
Dosage: Clinician-directed only.
Function/Mechanism: Precursor to glutathione; modulates mucus/oxidative stress.

9) Flaxseed oil (ALA source)
Description: Plant-based omega-3 (ALA) that converts partly to EPA/DHA; option for those avoiding fish.
Dosage: Per product; discuss with clinician.
Function/Mechanism: Anti-inflammatory lipid support.

10) Probiotics
Description: Gut-eye axis research is emerging; probiotics may help allergy/inflammation balance in some people.
Dosage: Product-specific; pediatric guidance needed.
Function/Mechanism: Immune modulation via gut microbiome.

---

Drugs for immunity booster / regenerative / stem-cell

There are no FDA-approved stem-cell drugs to correct BPES eyelid structure. Below are therapies discussed in broader ocular surface or wound-healing contexts. Use only under specialist care.

1) Autologous serum tears (specialist compounded)
Description (~100 words): Made from a patient’s own blood serum, these drops contain growth factors that can help severe surface dryness after surgeries in selected cases.
Dosage: Several times daily per specialist.
Function/Mechanism: Delivers epithelial growth factors and vitamins similar to natural tears.

2) Platelet-rich plasma (PRP) eye drops (compounded)
Description: PRP may aid healing in difficult surface cases; evidence is evolving.
Dosage: Per protocol.
Function/Mechanism: Platelet growth factors support epithelial repair.

3) Topical cenegermin (nerve growth factor) in select neurotrophic cases
Description: FDA-approved for neurotrophic keratitis, not for BPES itself; rare, specialist-directed use if corneal nerves are compromised.
Dosage: As per label when indicated.
Function/Mechanism: Supports corneal nerve and epithelial healing.

4) Amniotic membrane (device/biologic adjunct)
Description: Surgeon-placed membrane aids surface healing when needed.
Dosage: One-time placement.
Function/Mechanism: Provides growth factors and a scaffold for epithelial repair.

5) Topical cyclosporine (immunomodulator)
Description: Already listed above; here emphasized for chronic surface inflammation control in older patients.
Dosage: Twice daily.
Function/Mechanism: T-cell inhibition reduces inflammatory damage.

6) Lifitegrast (immunomodulator)
Description: As above; blocks T-cell adhesion to calm inflammation.
Dosage: Twice daily.
Function/Mechanism: LFA-1/ICAM-1 blockade.

---

Surgeries (procedures and why they are done)

1) Medial canthoplasty
Procedure: Reshapes the inner corner of the eyelids and releases the epicanthus inversus fold to open the horizontal fissure.
Why: Widens the eye opening and improves eyelid position near the nose for both function and appearance.

2) Lateral canthoplasty/canthopexy
Procedure: Tightens or repositions the outer corner to balance the eyelid shape after other steps.
Why: Improves eyelid support, symmetry, and horizontal width.

3) Ptosis repair (levator resection or advancement)
Procedure: Shortens or reattaches the main lifting muscle (levator) to raise the upper lid.
Why: Clears the pupil, improves vision, and reduces head tilt and brow strain.

4) Frontalis sling (silicone or other materials)
Procedure: Connects the upper lid to the forehead muscle so the brow can help lift the lid, used when the levator is very weak.
Why: Provides better lid elevation when native muscle strength is not enough.

5) Staged reconstructive approach
Procedure: Surgeons often perform procedures in planned stages as the child grows, sometimes starting with canthoplasty, then ptosis repair later.
Why: Staging balances safety, facial growth, and best long-term vision and appearance.

Evidence note: These procedures are standard reconstructive options listed in pediatric oculoplastic surgery texts and postoperative care guides.

---

Preventions

1. Keep regular eye appointments to catch amblyopia early.

2. Use prescribed glasses and patching plans as directed.

3. Practice good eyelid hygiene and use lubricants if advised.

4. Avoid eye rubbing; treat allergies to limit itch.

5. Wear UV-blocking sunglasses and hats outdoors.

6. Use protective eyewear for sports and active play.

7. Follow all pre- and post-surgery instructions carefully.

8. Maintain healthy sleep, hydration, and balanced diet.

9. Seek care quickly for redness, pain, discharge, or vision changes.

10. Share a care plan with school so supports are in place.

Evidence note: Preventive measures align with pediatric ophthalmology best practices.

---

When to see a doctor (red flags)

See an eye doctor right away if you notice: the pupil is covered most of the time; the child tilts the head or lifts brows to see; one eye turns in or out; the eyes are unequal in vision; there is redness, pain, light sensitivity, discharge, swelling, fever, or a sudden change after surgery; or the child falls behind in visual tasks. Adults with BPES should seek care for chronic dryness, recurrent infections, or any rapid vision change. People with suspected Type I BPES should also discuss reproductive health and timing with a clinician.

Evidence note: These triggers come from standard pediatric eye safety guidance and postoperative warning signs.

---

What to eat and what to avoid

Eat more:

1. Fatty fish (salmon, sardine) for omega-3s.

2. Leafy greens (spinach, kale) for lutein/zeaxanthin.

3. Citrus/berries for vitamin C.

4. Nuts/seeds for vitamin E and healthy oils.

5. Eggs for carotenoids and protein.

Limit/avoid:

1.  Very dry, salty snacks that worsen dehydration if overused.
2. Sugary drinks that displace water intake.
3. Excess alcohol in adults (worsens dryness).
4. Smoke exposure, which irritates eyes.
5. Redness-relief” drops overuse (rebound redness risk) unless prescribed.

Evidence note: Nutrition suggestions follow common ocular surface comfort guidance.

---

Frequently Asked Questions

1) Is BPES dangerous to the brain or intelligence?
No. BPES changes the eyelids, not the brain. With proper eye care and surgery when needed, children can see and develop normally. Evidence note: Clinical experience and genetic disorder summaries.

2) Can BPES go away on its own?
No. It is a structural eyelid condition present from birth. Eyelid surgery is usually needed for function and appearance. Evidence note: Pediatric oculoplastic practice.

3) When is the best time for surgery?
Timing is individualized. Surgeons consider vision risk, severity, and growth. Some parts may be done earlier to protect vision, with other steps later. Evidence note: Staged reconstruction principles.

4) Will my child need more than one surgery?
Often yes. As the face grows, adjustments can be needed. Evidence note: Long-term follow-up data in congenital eyelid repair.

5) Can glasses or drops fix BPES?
No. Glasses and drops help vision and comfort but do not change eyelid shape. Evidence note: Role of medical vs surgical management.

6) Is BPES inherited?
Often yes (autosomal dominant), but new variants occur. Genetic counseling can help families plan. Evidence note: FOXL2 inheritance patterns.

7) What is the difference between Type I and Type II BPES?
Type I includes eyelid findings plus reduced ovarian function in many affected individuals; Type II has eyelid findings only. Evidence note: FOXL2 phenotype descriptions.

8) Will surgery leave scars?
Surgeons hide incisions in natural creases. Some redness or swelling is normal early and fades over time. Evidence note: Standard postoperative course.

9) How do we prevent lazy eye?
Early exams, glasses, patching when needed, and timely surgery to clear the pupil help protect vision. Evidence note: Amblyopia prevention guidelines.

10) Are contact lenses safe with BPES?
Sometimes, in older patients with proper fit and hygiene. A specialist must check lid position and tear quality. Evidence note: Contact lens fitting standards.

11) Can BPES affect tearing or tear drainage?
Yes, the inner lid anatomy can change tear flow. The doctor will check for overflow tearing and blocked ducts. Evidence note: Lacrimal system evaluations.

12) Do omega-3 supplements really help?
They can help some people with dry eye features, but results vary. Food sources are a good start. Evidence note: Ocular surface nutrition literature.

13) Is school activity safe after surgery?
Most children return after the surgeon clears them, with limits on rough play for a time. Evidence note: Post-op activity guidance.

14) Will my child look “normal” after surgery?
Surgery aims to improve both function and appearance. Final look varies by anatomy and healing. Evidence note: Outcome discussions in oculoplastics.

15) Can BPES be cured with stem cells now?
No established stem-cell cure exists for eyelid structure in BPES. Research continues for eye surface healing, but not for changing eyelid shape. Evidence note: Current clinical practice and FDA approvals.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: October 28, 2025.